SYK · NYSE · STOCK
Stryker (SYK) Stock Analysis
$277.22
52W $267.00 – $392.55
61/100
$106.32B
28.5
0.78
Is SYK Bullish or Bearish?
Bullish.
Innellis AI committee rates Stryker Corporation (SYK) Buy with a composite score of 61/100
, based on 5 analysts with 60% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +14.28 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -5.72 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — eps growing 27.7% yoy. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 16.4% shows genuine earnings power backing the valuation — Value
- EPS growing 27.7% YoY — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
- News sentiment is positive (+0.20 across 35 articles, 14d) — News
Bear Case
- P/E of 28.7 is moderate-to-rich — Value
- Price-to-book of 6.0x prices in significant intangible value — Value
- Price structure making lower highs and lower lows — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
61/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 31%
of 192 Healthcare peers
Value Analyst
neutral
48
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 16.4% shows genuine earnings power backing the valuation
− P/E of 28.7 is moderate-to-rich
Growth Analyst
bullish
70
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 27.7% YoY
Technical Analyst
neutral
56
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 35 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 60.7 to 60.7.
- New bearish signals: 1 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- News Analyst: +1 bullish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
47.6
Neutral
MACD Histogram
2.158
Bullish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Mixed
Support
$267.03
Resistance
$352.41
Bollinger %B
0.51
Inside Bands
Price vs Moving Averages
EMA 9
$277.24
Below
EMA 21
$281.57
Below
EMA 50
$295.58
Below
EMA 200
$323.86
Below
Fundamental Analysis
Valuation
66
Growth
57
Profitability
78
Financial Health
97
Cash Flow
70
Valuation
P/E Ratio
28.5×
P/B Ratio
4.43×
PEG Ratio
1.05
Dividend Yield
1.27%
52W High
$392.55
52W Low
$267.00
Quality & Growth
ROE
1447.8%
ROA
678.5%
Gross Margin
6516.6%
Operating Margin
2202.7%
Revenue Growth YoY
—
Debt / Equity
0.62
AI Fundamental Assessment
P/E ratio of 28.5 (moderate relative to a 15-40x range); Price-to-book of 4.4x; PEG ratio of 1.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 14.5%; Return on assets of 6.8%; Net margin of 14.4%; Gross margin of 65.2%; Current ratio of 2.16 (healthy short-term liquidity); Debt-to-equity of 0.62; Free cash flow per share is positive (12.26); Most recent quarter beat estimates by 4.7%; EPS growth accelerating (-41.8% -> +41.9% QoQ); Analyst estimates falling over recent quarters
Get the Full SYK Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →